(BLD) Topbuild - NYSE
Sector: Industrials | Industry: Engineering & Construction | Exchange: NYSE (USA) | Market Cap: 11.954m USD | Total Return: 35% in 12m
Avg Turnover: 310M
EPS Trend: 24.1%
Qual. Beats: 0
Rev. Trend: 76.1%
Qual. Beats: 1
Warnings
Fakeout
Tailwinds
No distinct edge detected
TopBuild Corp. (BLD) is a leading installer and distributor of insulation and building material products within the North American construction market. The company operates through two primary segments: Installation, which provides direct labor and materials for residential and commercial projects, and Specialty Distribution, which supplies insulation and accessories to a broad network of contractors and dealers.
The business model relies heavily on a hub-and-spoke distribution network that leverages scale to optimize procurement from major insulation manufacturers. As a key player in the building materials sector, TopBuild benefits from increasing regulatory focus on energy efficiency standards, which often mandates higher R-value insulation requirements in new construction and retrofits.
The company’s service portfolio extends beyond insulation to include gutters, garage doors, fireplaces, and commercial roofing systems across the United States and Canada. Investors can use ValueRay to further analyze the companys historical performance and valuation metrics. Headquartered in Daytona Beach, Florida, TopBuild serves a diverse client base ranging from national homebuilders to industrial general contractors.
- Residential housing starts and multi-family construction activity dictate volume demand
- Strategic acquisitions of regional insulation installers drive inorganic revenue growth
- Fluctuations in fiberglass and spray foam costs impact gross profit margins
- Commercial and industrial insulation demand provides essential counter-cyclical revenue diversification
- Mortgage rate volatility influences single-family home completion schedules and installation backlogs
| Net Income: 503.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -4.45 > 1.0 |
| NWC/Revenue: 15.60% < 20% (prev 14.30%; Δ 1.30% < -1%) |
| CFO/TA 0.11 > 3% & CFO 764.5m > Net Income 503.2m |
| Net Debt (3.15b) to EBITDA (991.0m): 3.18 < 3 |
| Current Ratio: 2.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.1m) vs 12m ago -3.58% < -2% |
| Gross Margin: 28.78% > 18% (prev 30.07%; Δ -1.30% > 0.5%) |
| Asset Turnover: 99.43% > 50% (prev 115.0%; Δ -15.54% > 0%) |
| Interest Coverage Ratio: 6.47 > 6 (EBIT TTM 801.1m / Interest Expense TTM 123.8m) |
| A: 0.13 (Total Current Assets 1.76b - Total Current Liabilities 879.6m) / Total Assets 6.71b |
| B: 0.54 (Retained Earnings 3.62b / Total Assets 6.71b) |
| C: 0.14 (EBIT TTM 801.1m / Avg Total Assets 5.65b) |
| D: 0.56 (Book Value of Equity 2.40b / Total Liabilities 4.31b) |
| Altman-Z'' = 4.15 = AA |
| DSRI: 1.17 (Receivables 930.5m/748.7m, Revenue 5.62b/5.28b) |
| GMI: 1.05 (GM 30.07% / 28.78%) |
| AQI: 1.13 (AQ_t 0.66 / AQ_t-1 0.58) |
| SGI: 1.06 (Revenue 5.62b / 5.28b) |
| TATA: -0.04 (NI 503.2m - CFO 764.5m) / TA 6.71b) |
| Beneish M = -2.73 (Cap -4..+1) = A |
As of June 20, 2026, the stock is trading at USD 426.51 with a total of 1,285,400 shares traded.
Over the past week, the price has changed by +4.07%,
over one month by +7.09%,
over three months by +22.92% and
over the past year by +34.96%.
Topbuild has received a consensus analysts rating of 4.17. Therefore, it is recommended to buy BLD.
- StrongBuy: 6
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 473.8 | 11.1% |
P/E Trailing = 23.9161
P/E Forward = 23.2019
P/S = 2.1265
P/B = 4.8697
Revenue TTM = 5.62b USD
EBIT TTM = 801.1m USD
EBITDA TTM = 991.0m USD
Long Term Debt = 2.77b USD (from longTermDebt, last quarter)
Short Term Debt = 156.4m USD (from shortTermDebt, last quarter)
Debt = 3.42b USD (from shortLongTermDebtTotal, last quarter) + Leases 295.0m
Net Debt = 3.15b USD (calculated: Debt 3.42b - CCE 268.8m)
Enterprise Value = 15.1b USD (12.0b + Debt 3.42b - CCE 268.8m)
Interest Coverage Ratio = 6.47 (Ebit TTM 801.1m / Interest Expense TTM 123.8m)
EV/FCF = 21.45x (Enterprise Value 15.1b / FCF TTM 704.4m)
FCF Yield = 4.66% (FCF TTM 704.4m / Enterprise Value 15.1b)
FCF Margin = 12.53% (FCF TTM 704.4m / Revenue TTM 5.62b)
Net Margin = 8.95% (Net Income TTM 503.2m / Revenue TTM 5.62b)
Gross Margin = 28.78% ((Revenue TTM 5.62b - Cost of Revenue TTM 4.00b) / Revenue TTM)
Gross Margin QoQ = 27.68% (prev 27.24%)
Tobins Q-Ratio = 2.25 (Enterprise Value 15.1b / Total Assets 6.71b)
Interest Expense / Debt = 3.62% (Interest Expense 123.8m / Debt 3.42b)
Taxrate = 25.72% (174.2m / 677.4m)
NOPAT = 595.1m (EBIT 801.1m * (1 - 25.72%))
Current Ratio = 2.00 (Total Current Assets 1.76b / Total Current Liabilities 879.6m)
Debt / Equity = 1.42 (Debt 3.42b / totalStockholderEquity, last quarter 2.40b)
Debt / EBITDA = 3.18 (Net Debt 3.15b / EBITDA 991.0m)
Debt / FCF = 4.48 (Net Debt 3.15b / FCF TTM 704.4m)
Total Stockholder Equity = 2.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.90% (Net Income 503.2m / Total Assets 6.71b)
RoE = 22.15% (Net Income TTM 503.2m / Total Stockholder Equity 2.27b)
RoCE = 15.89% (EBIT 801.1m / Capital Employed (Equity 2.27b + L.T.Debt 2.77b))
RoIC = 10.41% (NOPAT 595.1m / Invested Capital 5.72b)
WACC = 9.75% (E(12.0b)/V(15.4b) * Re(11.77%) + D(3.42b)/V(15.4b) * Rd(3.62%) * (1-Tc(0.26)))
Discount Rate = 11.77% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.56 | Cagr: -5.31%
[DCF] Terminal Value 71.07% ; FCFF base≈697.4m ; Y1≈715.1m ; Y5≈789.9m
[DCF] Fair Price = 238.7 (EV 9.87b - Net Debt 3.15b = Equity 6.72b / Shares 28.1m; r=9.75% [WACC]; 5y FCF grow 2.54% → 2.50% )
EPS Correlation: 24.07 | EPS CAGR: 1.00% | SUE: 0.57 | # QB: 0
Revenue Correlation: 76.12 | Revenue CAGR: 2.05% | SUE: 2.24 | # QB: 1
EPS current Quarter (2026-06-30): EPS=4.80 | Chg30d=+0.73% | Revisions=+0% | Analysts=11
EPS next Quarter (2026-09-30): EPS=5.13 | Chg30d=-0.96% | Revisions=+17% | Analysts=11
EPS current Year (2026-12-31): EPS=18.20 | Chg30d=+0.01% | Revisions=-17% | GrowthEPS=-7.9% | GrowthRev=+12.2%
EPS next Year (2027-12-31): EPS=20.93 | Chg30d=-0.10% | Revisions=-9% | GrowthEPS=+15.0% | GrowthRev=+4.2%
[Analyst] Revisions Ratio: +17%